Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter Barton Hutt Insider Profile
4 Followers
Peter Barton Hutt, Director at Salarius Pharmaceuticals, holds 11.68K shares in Salarius Pharmaceuticals (Ticker: SLRX), holds ― shares in Seres Therapeutics (Ticker: MCRB), holds 0.00 shares in Immunomedics (Ticker: IMMU).
Peter Barton Hutt Salarius Pharmaceuticals (SLRX)Director
Salarius Pharmaceuticals (SLRX)
Director
Ranked #78,050 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 8 Profitable Transactions
Average Return
-113.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Barton Hutt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Barton Hutt
Peter Barton Hutt's Trading History
Salarius Pharmaceuticals
Feb 04, 2015
Director
Uninformative Buy
―
$7.99K
Seres Therapeutics
―
Director
―
―
Immunomedics
Oct 23, 2020
―
Uninformative Sell
―
$0.00
Moderna
Nov 22, 2019
Director
Informative Sell
4.04M
$498.47K
Concert Pharma
Sep 01, 2020
Director
Informative Buy
13.41K
$90.54K
Xoma
―
Director
―
$0.00
DNIB Unwind, Inc.
Aug 30, 2016
―
Informative Buy
6.60K
$0.00
Momenta Pharma
Sep 15, 2014
―
Informative Sell
41.57K
$352.93K
List of latest transactions for each holding click on a transaction to see Peter Barton Hutt's performance on stock
You May Also Like
Peter Barton Hutt insider profile FAQ
What is the percentage of profitable transactions made by Peter Barton Hutt?
The percentage of profitable transactions made by Peter Barton Hutt is 25%.
What is the average return per transaction made by Peter Barton Hutt?
The average return per transaction made by Peter Barton Hutt is -113.90%.
What stocks does Peter Barton Hutt hold?
Peter Barton Hutt holds: SLRX, MCRB, IMMU, MRNA, CNCE, XOMA, BINDQ, MNTA stocks.
What was Peter Barton Hutt’s latest transaction?
Peter Barton Hutt latest transaction was an Uninformative Buy of ―.
What was Peter Barton Hutt's most profitable transaction?
Peter Barton Hutt’s most profitable transaction was an Informative Buy of CNCE stock on September 1, 2020. The return on the trade was 18.30%.
What is Peter Barton Hutt's role in Salarius Pharmaceuticals?
Peter Barton Hutt's role in Salarius Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.